Home Physical Sciences On the Reality of Virtual Libraries
Article Publicly Available

On the Reality of Virtual Libraries

  • by Paul Erhardt
Published/Copyright: September 1, 2009
Become an author with De Gruyter Brill

_

IUPAC Forum

_

On the Reality of Virtual Libraries

by Paul Erhardt

During one of the activities of the Chemistry and Human Health Division, namely a medicinal chemistry subsection meeting directed toward harmonizing nomenclature in the area of combinatorial chemistry, we became aware of a movement to obtain patent protection of virtual libraries. Such patents have been sought most often on the basis that a library has been pre-selected to be "drug like" in its make up. Along these same lines, it appears that Chemical Abstracts Service CA Registry numbers are now being sought for the compound members within virtual libraries. Concerned about these developments for the reasons mentioned below, we welcome the views of the readership to clarify what position might actually be best to advocate as we all continue to proceed into the rapidly evolving future of drug discovery.

Since its formalization as a discipline nearly 100 years ago, medicinal chemists have contemplated what structural features a new therapeutic agent ought to contain in order to exhibit the most desirable pharmacological profile. Simply drawing such conceptions on paper, however, has never been regarded as an adequate basis for a patent even when the conceived family of structures is new and novel. This is because the patenting process has traditionally also emphasized a reduction to practice (e.g., actual synthesis of a number of representatives so as to encompass the breadth or "scope" of the proposed family of structures) along with a demonstration of potential utility by at least a real, if not the preferred, embodiment of the concept (e.g., positive responses from the synthesized members upon their study in a biological model indicative of the anticipated response being sought in humans).

Today, it is possible with the aid of computers, to draw huge numbers of "virtual compounds" that can be thought of as drug like in their overall character based upon our notions of what types of parameters are generally required for such behavior. While this might constitute conception relative to a particular molecular scaffold to be deployed for a given therapeutic indication, it does not constitute either a reduction to practice or an actual demonstration of utility. In some ways, this situation is reminiscent of issues raised within the Journal of Medicinal Chemistry several years ago. In the midst of the so-called "heyday of rational drug design," this audience stepped forward to express its reluctance to engage in the wholesale publication of proposed new drug molecules that had not actually been synthesized. This is because it was recognized that this type of public disclosure could bar the patenting of such structures at a later point and could thus serve to discourage, rather than to encourage, the true pursuit of compounds deemed to be of therapeutic value. Finally, it might also be suggested that for similar reasons, prudence ought to be exercised relative to the potential assignment of CA Registry numbers to virtual compounds whether or not patents are being pursued.

Paul Erhardt is a professor at the University of Toledo, Ohio, USA, and is the director of the University Center for Drug Design & Development. He is also the current vice president of the IUPAC Chemistry and Human Health Division.

Published Online: 2009-09-01
Published in Print: 2002-07

© 2014 by Walter de Gruyter GmbH & Co.

Articles in the same Issue

  1. Contents
  2. Vice President’s Column
  3. IUPAC in a Changing World
  4. XML in Chemistry
  5. Crystallographic Information File (CIF)
  6. How Well Are We Using XML in Chemistry?
  7. Markup Languages–How to Structure Chemistry-Related Documents
  8. A Preprint Server for Chemistry
  9. IUPAC Forum
  10. On the Reality of Virtual Libraries
  11. IUPAC News
  12. The Analytical Chemistry Division
  13. IUPAC Projects
  14. Pest Management for Small-Acreage Crops: A Cooperative Global Approach
  15. Provisional Recommendations
  16. IUPAC Seeks Your Comments
  17. Highlights from Pure and Applied Chemistry
  18. Presenting recently published IUPAC technical reports and recommendations. Critical Evaluation of Proven Chemical Weapon Destruction Technologies (IUPAC Technical Report)
  19. Definitions of Basic Terms Relating to Polymer Liquid Crystals (IUPAC Recommendations 2001)
  20. New Books and Publications
  21. Interactions Between Soil Particles and Microorganisms: Impact on the Terrestrial Ecosystem
  22. Non-Conventional Polymer Dispersions
  23. Solubility of Ethyne in Liquids
  24. IUPAC Handbook 2002–2003
  25. Handbuch für die Systematische Nomenklatur der Organischen Chemie
  26. Reports from Conferences
  27. Chemistry and Quality of Life
  28. Macromolecules-Metal Complexes
  29. Ionic Polymerization
  30. Polymer Characterization
  31. Heterocyclic Chemistry
  32. On the Web
  33. Co-Operation on International Traceability in Anaytical Chemistry (CITAC)
  34. The International Network for the Availability of Scientific Publications (INASP)
  35. Visualized Thermodynamics
  36. Conference Announcements
  37. Purchasing, Servicing and Maintenance of Scientific Equipment 5-8 November 2002, Cameroon
  38. 2nd European Symposium on Clinical Laboratory and In Vitro Diagnostic Industry 6-7 February 2003, Barcelona, Catalonia, Spain
  39. Conference Announcements in Brief
  40. Calendar of IUPAC Sponsored Conferences
Downloaded on 27.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ci.2002.24.4.16a/html
Scroll to top button